Skip to main content
. 2021 Jun;13(6):3518–3528. doi: 10.21037/jtd-21-340

Table 2. Post NACI CT evaluation.

Parameters pre-NACI CT, N=19 (%) post-NACI CT, N=19 (%)
Tumor
   T2 0 (0) 3 (15.79)
   T3 18 (94.97) 15 (78.91)
   T4a 1 (5.26) 1 (5.26)
Lymph node
   N1 13 (68.42) 16 (84.21)
   N2 5 (26.32) 2 (10.53)
   N3 1 (5.26) 1 (5.26)
cTNM stage
   III 13 (68.42) 16 (84.21)
   IVA 6 (31.58) 3 (15.79)
Response rate
   PR 13 (68.42)
   SD 6 (31.58)

NACI, neoadjuvant chemotherapy combined with immunotherapy.